HCM
ALT icon

Hollencrest Capital Management’s Altimmune ALT Stock Holding History

Hollencrest Capital Management’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-770
Closed -$2.9K – 1172
2025
Q3 		$2.9K Hold
770
– – ﹤0.01% 952
2025
Q2 		$2.98K Hold
770
– – ﹤0.01% 925
2025
Q1 		$3.85K Hold
770
– – ﹤0.01% 903
2024
Q4 		$5.55K Hold
770
– – ﹤0.01% 877
2024
Q3 		$4.73K Hold
770
– – ﹤0.01% 865
2024
Q2 		$5.12K Buy
+770
New +$5.68K ﹤0.01% 835

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Hollencrest Capital Management's ALT Position: Q4 2025 in Review

Hollencrest Capital Management sold out of Altimmune (ALT) in Q4 2025, closing a stake of 770 shares — an estimated $2.9K sold.

Hollencrest Capital Management first reported a position in ALT in Q2 2024 and held it in 6 quarters. The position peaked at $5.55K in Q4 2024. 181 funds tracked by Wall St. Rank hold ALT as of Q4 2025.

  • Hollencrest Capital Management reported no remaining Altimmune position as of Q4 2025 after selling out during the quarter.
  • Hollencrest Capital Management sold 770 Altimmune shares in Q4 2025, an estimated $2.9K.
  • Hollencrest Capital Management first reported a position in Altimmune in Q2 2024 and held it in 6 quarters.
  • Hollencrest Capital Management's Altimmune position peaked at $5.55K in Q4 2024.
  • 181 funds tracked by Wall St. Rank held Altimmune as of Q4 2025.

Based on Hollencrest Capital Management's 13F filing for Q4 2025, filed 12 Feb 2026.